• Deuterium-Labeled Degarelix: Synthesis and Significance

  2026-09-01

  The reference study reports an efficient 13-step synthesis of deuterium-labeled degarelix acetate, using D2O/D3PO4-mediated exchange to prepare a d7-naphthyl amino-acid building block before peptide assembly. The resulting 14% overall route provides a practical source of a stable-isotope internal standard for pharmacokinetic and ADME investigations of degarelix.

• Uridine, Trisodium Salt for RNA Workflow Design

  2026-08-31

  Uridine, Trisodium Salt supports carefully controlled RNA metabolism, enzymatic RNA biosynthesis, and tissue-response experiments without being confused with activated uridine nucleotides. This guide translates the PRINT safe-harbor insertion study into practical assay controls while showing where the reagent is—and is not—a suitable workflow component.

• CYR61, Migrasomes, and Repair of Irradiated BMSCs

  2026-08-31

  A 2025 Stem Cells International study identifies CYR61-loaded migrasomes as a mediator of migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells. The work connects CYR61 binding to integrin αvβ3 and ERK activation, while offering a mechanistic framework for studying cell-based repair of osteoradionecrosis-related defects.

• Sulfo-Cy3 NHS Ester for Reliable Cell Assays

  2026-08-30

  This scenario-based guide explains how Sulfo-Cy3 NHS ester, SKU A8107, can support protein-tracking workflows linked to cell viability, proliferation, and cytotoxicity assays. It covers amine labeling chemistry, aqueous handling, protocol controls, fluorescence interpretation, storage, and practical vendor-selection criteria.

• MDL 28170: Calpain Control for Translational Research

  2026-08-29

  MDL 28170 is a cell-permeable calpain and cathepsin B inhibitor that connects mechanistic protease biology with neuroprotection research, apoptosis assays, ischemia-reperfusion injury models, and infection studies. This thought-leadership perspective examines how to use the compound to test causality, improve experimental design, and avoid overstating preclinical evidence.

• Intravesical p21 mRNA–LNP Therapy for Bladder Cancer

  2026-08-28

  The reference study develops a nonviral, bladder-localized tumor suppressor replacement strategy using chemically modified CDKN1A/p21 mRNA in lipid nanoparticles. Its combination of localized expression, cell-cycle inhibition, DNA-damage signaling, and tumor suppression in an orthotopic model supports further investigation of intravesical mRNA delivery while leaving formulation-specific questions open.

• Patient-Derived Gastric Cancer Assembloids Explained

  2026-08-28

  This 2025 study develops patient-matched gastric cancer assembloids that combine tumor organoids with distinct stromal cell populations from the same specimen. The model captures microenvironment-dependent gene expression and drug-response heterogeneity, offering a more physiologically relevant framework for biomarker discovery, resistance studies, and personalized screening.

• Tofacitinib Repairs GM-CSF–Driven RA Macrophages

  2026-08-27

  The 2026 reference study shows that GM-CSF reprograms rheumatoid arthritis macrophages into an inflammatory, metabolically stressed state marked by oxidative damage and mitochondrial fragmentation. Tofacitinib reversed this phenotype more broadly than metabolic inhibitors by reducing GM-CSFRα expression, limiting STAT5 signaling, restoring regulatory markers, and rebalancing mitochondrial function.

• Tetraethylammonium Chloride for Translational K+ Research

  2026-08-27

  Tetraethylammonium chloride (TEAC) is more than a conventional potassium channel blocker. Its access to internal and external pore sites makes it a practical mechanistic probe for connecting ion conduction, vascular physiology, and translational assay design.

• Leucovorin Calcium in Gastric Cancer Assays

  2026-08-26

  Use calcium folinate as a mechanistic rescue control in methotrexate challenge studies, then test whether patient-matched stromal cells alter that response. This workflow connects folate metabolism experiments with gastric cancer assembloid screening while keeping product handling and assay interpretation practical.

• Disodium bicinchoninate: Aqueous Research Reagent

  2026-08-26

  Disodium bicinchoninate is the water-soluble sodium [2,2'-biquinoline]-4,4'-dicarboxylate salt supplied as SKU C6645. Its reported 98.00% purity, aqueous solubility, and chelating-agent profile support biochemical and molecular biology workflows, but the cited cardiovascular study does not establish it as a PDE-5 inhibitor or medical treatment.

• ddATP for DNA Synthesis Termination Workflows

  2026-08-25

  ddATP gives researchers a controllable way to stop nascent DNA selectively at positions requiring adenine incorporation, supporting sequencing, polymerase assays, and DNA-damage studies. Its use as a mechanistic perturbation is especially valuable when paired with EdU synthesis labeling and cH2A.X damage readouts in oocyte models.

• Polymer Pen Lithography for Tunable 3D SERS Arrays

  2026-08-25

  The reference study introduces a polymer pen lithography route for constructing ordered three-dimensional gold nanoparticle cluster arrays on patterned polyethylenimine scaffolds. By adjusting the lithographic pattern and array architecture, the authors obtained strong SERS enhancement together with low signal variation, offering a structurally tunable alternative to less reproducible nanoparticle aggregation methods.

• Acetoacetic Acid Sodium Salt for Reliable Assays

  2026-08-24

  This scenario-based guide explains how Acetoacetic acid sodium salt (SKU A9940) can improve control of matrix, concentration, storage, and interpretation problems in cell viability, proliferation, and cytotoxicity assays. It combines product specifications with practical decision points for energy metabolism research, diabetes metabolic imbalance, and ketone-body experiments.

• MK-8745: A Potent Aurora A Inhibitor Workflow

  2026-08-24

  MK-8745 converts Aurora A biology into a practical workflow for measuring mitotic arrest, tetraploidy, and apoptosis across cancer models. Its strong biochemical potency, defined handling requirements, and relevance to high-risk retinoblastoma research support a disciplined path from cell assays to xenograft hypotheses.

7879 records 1/526 page Next 12345 下5页 Last page